Rhabdomyosarcoma trial engagement study
Part of Cancer clinical trials.
This study looks at what makes people with rhabdomyosarcoma join or stay in clinical trials. It is an observational study, not a treatment test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rhabdomyosarcoma
- You are able to understand and follow study procedures
- You sign a consent form agreeing to take part
- You are not currently in another trial or recently finished one with an investigational drug
- You are not pregnant, breastfeeding, or planning to get pregnant during the study
- You do not have a serious, unstable medical condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different treatment approaches for rhabdomyosarcoma (RMS) in children and adults, including newly diagnosed high-risk cases, people needing radiotherapy, and people whose RMS has returned. It’s designed to find safer dosing and more effective therapy while checking whether participants can proceed based on health and timing requirements.
This study tests different treatment plans for children with rhabdomyosarcoma based on their individual risk factors. It aims to find the best therapy for each child, potentially improving outcomes.
This study uses a special machine to find unique protein patterns in rhabdomyosarcoma tumor samples from children and young adults. By analyzing leftover tissue from past biopsies or surgeries, researchers hope to better understand the disease and improve future treatments.
This trial compares two different chemotherapy schedules for children and young adults with intermediate-risk rhabdomyosarcoma (a type of muscle cancer). One group gets a higher dose of chemotherapy over a shorter period, while the other gets a lower dose plus maintenance therapy for a longer time. The goal is to see which approach works better.
This trial tests a personalized mRNA vaccine for people with rhabdomyosarcoma that hasn't responded to other treatments. The vaccine is designed to help your immune system fight the cancer.
This trial tests whether a cancer immunotherapy medicine (atezolizumab) given together with chemotherapy can shrink or control solid tumors that have come back or did not respond to prior treatment. It focuses on children and young adults, including a special subgroup for rhabdomyosarcoma.
Hear when a new Rhabdomyosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.